Physician profile
Sanjay Ramakumar
NPI 1437255742
$7,198.37
in general payments reported to CMS, 2019-2025
25 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $635 · 2020: $207 · 2021: $23.66 · 2022: $558 · 2023: $2,796 · 2024: $1,857 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,699 · Travel and Lodging: $2,061 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,698.54 |
| Travel and Lodging | $2,061.25 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,970.78 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Procept Biorobotics Corporation | $569.19 | 2022-2023 | Aquabeam Robotic System |
| Teleflex LLC | $560.17 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $410.76 | 2019-2024 | Lithovue, Spaceoar System, Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $248.42 | 2023 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $213.28 | 2019-2023 | Provenge |
| Conmed Corporation | $198.40 | 2022-2023 | Airseal |
| Coloplast Corp | $190.59 | 2019-2023 | Speedicath, Sensura Mio |
| Innovation Technologies INC | $116.02 | 2023 | Irrisept |
| Ambu INC. | $103.22 | 2023 | |
| Janssen Biotech, INC. | $86.14 | 2019-2023 | Erleada |
| Pfizer INC. | $83.29 | 2019-2023 | |
| Blue Earth Diagnostics | $72.46 | 2019 | |
| Histosonics, INC. | $64.47 | 2024 | |
| Neotract INC. | $55.05 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.31 | 2019-2023 | Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $47.41 | 2019 | |
| Myriad Genetic Laboratories, INC. | $40.46 | 2023 | Prolaris |
| Astellas Pharma US INC | $27.78 | 2019 | |
| 180 Medical, INC. | $24.03 | 2023 | Gentlecath Glide |
| Sun Pharmaceutical Industries INC. | $21.46 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.84 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $13.27 | 2020 | |
| Therapeuticsmd, INC. | $11.57 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Ramakumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.